These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37117112)

  • 1. Physician Perception of Grade Group 1 Prostate Cancer.
    Saoud R; Woranisarakul V; Paner GP; Ramotar M; Berlin A; Cooperberg M; Eggener SE
    Eur Urol Focus; 2023 Nov; 9(6):966-973. PubMed ID: 37117112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
    Tosoian JJ; Mamawala M; Epstein JI; Landis P; Macura KJ; Simopoulos DN; Carter HB; Gorin MA
    Eur Urol; 2020 Jun; 77(6):675-682. PubMed ID: 31918957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysis.
    Nayak JG; Drachenberg DE; Mau E; Suderman D; Bucher O; Lambert P; Quon H
    BMC Urol; 2014 Oct; 14():82. PubMed ID: 25339410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
    Rubin MA; Bismar TA; Curtis S; Montie JE
    Am J Surg Pathol; 2004 Jul; 28(7):946-52. PubMed ID: 15223967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Competing Risk of Mortality to Inform the Transition from Prostate Cancer Active Surveillance to Watchful Waiting.
    Huang MM; Alam R; Gabrielson AT; Su ZT; Kassiri B; Fletcher SA; Biles MJ; Patel HD; Pavlovich CP; Schwen ZR
    Eur Urol Focus; 2022 Sep; 8(5):1141-1150. PubMed ID: 34344628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?
    Herlemann A; Overland MR; Washington SL; Cowan JE; Westphalen AC; Carroll PR; Nguyen HG; Shinohara K; Cooperberg MR
    Eur Urol Focus; 2021 Nov; 7(6):1268-1273. PubMed ID: 32868222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
    Surcel CI; Sooriakumaran P; Briganti A; De Visschere PJ; Fütterer JJ; Ghadjar P; Isbarn H; Ost P; Ploussard G; van den Bergh RC; van Oort IM; Yossepowitch O; Sedelaar JP; Giannarini G; ;
    BJU Int; 2015 Apr; 115(4):571-9. PubMed ID: 24802335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
    Kato T; Tohi Y; Honda T; Matsuda I; Osaki Y; Naito H; Matsuoka Y; Okazoe H; Taoka R; Tsunemori H; Ueda N; Sugimoto M
    Int J Urol; 2023 Mar; 30(3):289-297. PubMed ID: 36415128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance for low-risk prostate cancer: diversity of practice across Europe.
    Azmi A; Dillon RA; Borghesi S; Dunne M; Power RE; Marignol L; O'Neill BD
    Ir J Med Sci; 2015 Jun; 184(2):305-11. PubMed ID: 24652265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
    van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis.
    Björklund J; Cheung DC; Martin LJ; Komisarenko M; Lajkosz K; Hamilton RJ; Zlotta AR; Finelli A
    Scand J Urol; 2023; 57(1-6):29-35. PubMed ID: 36683418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived Role of Social Media in Urologic Knowledge Acquisition Among Young Urologists: A European Survey.
    Rivas JG; Socarras MR; Patruno G; Uvin P; Esperto F; Dinis PJ; Roupret M; Borgmann H
    Eur Urol Focus; 2018 Sep; 4(5):768-773. PubMed ID: 28753825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.